Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2006. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2574706016 | Amphotericin (lipid formulation) 100mg powder for infusion solution vial (product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2578103010 | Amphotericin (lipid formulation) 100mg powder for infusion solution vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2580411019 | Amphotericin (colloidal dispersion) 100mg powder for infusion solution vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2580412014 | Amphotericin (lipid complex) 100mg powder for infusion solution vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2580413016 | Amphotericin (liposomal) 100mg powder for infusion solution vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Amphotericin (lipid formulation) 100mg powder for infusion solution vial | Is a | Product containing amphotericin B liposome | false | Inferred relationship | Existential restriction modifier | ||
| Amphotericin (lipid formulation) 100mg powder for infusion solution vial | Has manufactured dose form | Injection | false | Inferred relationship | Existential restriction modifier | ||
| Amphotericin (lipid formulation) 100mg powder for infusion solution vial | Has active ingredient | Amphotericin B liposome | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR